This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Whether your concern is pharmaceutical R&D, clinical studies or marketing — when it comes to pharma compliance, there’s only one authority.
Produced by the British Pharmacopoeia Commission Secretariat, the British Pharmacopoeia 2014 is the official, authoritative collection of standards for UK medicinal products and pharmaceutical substances.
Now used in almost 100 countries, the British Pharmacopoeia remains the must-have reference for pharmaceutical researchers and manufacturers, pharmacists, chemists, biotechnologists, quality assurance and quality control inspectors, laboratory technicians and regulatory bodies.
British Pharmacopoeia 2014 comprises a series of 3,500+ monographs each legally enforced by the Human Medicines Regulations 2012. Where a pharmacopoeial monograph exists, medicinal products sold or supplied in the UK must comply with the relevant monograph. All monographs and requirements for the European Pharmacopoeia are also reproduced in the BP.
Key Features in the 2014 edition:
• A six-volume printed set with a fully searchable CD-ROM and online access to provide you with a flexible resource
• 40 new BP monographs
• 3 new BP and 1 new BP (Vet) supplementary chapters
• 272 amended monographs
• Four new BP (Vet) monographs
• All current European Pharmacopoeia monographs
You’ll also find detailed information and guidance on various aspects of current pharmacopoeia policy and practice in supplementary chapters.
![Alison Bryant, senior consultant at Antea Group and communications director for the Healthcare Plastics Recycling Council (HPRC), addressed the crowd at the[PACK]out.](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2024/05/Alison_Bryant.6644005a513b0.png?auto=format%2Ccompress&fit=crop&h=167&q=70&w=250)
